Back
Corporate News
Asston Pharmaceuticals to review financial statements at board meeting on November 12
05-Nov-2026, 06:35
Asston Pharmaceuticals Limited, formerly Asston Pharmaceuticals Private Limited, will hold a board meeting on Thursday, November 12, 2026, to consider and approve the unaudited financial statements along with a limited review report for the half-year ended September 30, 2026, according to a regulatory filing with the BSE Limited.
